First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study

Siow Ming Lee, Christian Schulz, Kumar Prabhash, Dariusz M. Kowalski, Aleksandra Szczęsna, Baohui Han, Achim Rittmeyer, Toby Talbot, David Vicente, Raffaele Califano, Diego Cortinovis, Anh T. Le, Dingzhi Huang, Geoffrey Liu, Federico Cappuzzo, Jessica Reyes Contreras, Martin Reck, Ramón Palmero, Milena Perez Mak, Youyou Hu, Stefanie Morris, Elen Höglander, Mary M. Connors, Alice M. Biggane, Hans Kristian Moen Vollan, Solange Peters